Is It Time To Reassess 10x Genomics (TXG) After Its 105% One Year Surge

FierceBiotechReplimmune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection

10x Genomics Blog10x Genomics debuts Atera, a new platform to redefine how biology is measured and understood at AACR 2026 - SelectScience

IlluminaClinical Genomic Market: Growth and Outlook Driven by Illumina, - openPR.com

Thermo FisherAssessing Thermo Fisher Scientific (TMO) Valuation After New PCR Launch And Data Partnerships - simplywall.st

Curiosis Inc.Working capital per share of Curiosis, Inc. – KRX:494120 - TradingView

WatersWaters Corporation Schedules First Quarter 2026 Earnings Conference Call - ChartMill

Lonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract focus strong enough to unlock new ups - AD HOC NEWS

CellB cell deficiency limits exercise capacity by remodeling liver glutamate metabolism

CellA phytoscreen identifies a garlic compound as a deterrent of mating and egg laying in <em>Drosophila</em> and mosquitoes

Cellp53 safeguards chemical reprogramming of human somatic cells toward pluripotency

Cell2'3'-cGAMP-induced membrane shearing promotes broad antiphage immunity

CellGut microbiome is associated with recurrence-free survival in patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade